Reports for GE HEALTHCARE CANADA INC
Company Name
GE HEALTHCARE CANADA INC
Totals |
||
Shortage reports |
96 |
|
| Actual shortage: | 0 (0%) | |
| Anticipated shortage: | 1 (1%) | |
| Avoided shortage: | 6 (6%) | |
| Resolved: | 89 (93%) | |
Discontinuation Reports |
5 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 5 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
0 (0%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2019-06-19 | 2019-06-22 | 87081 |
| OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2020-07-28 | 2020-09-26 | 121295 |
| OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2020-08-14 | 2020-09-26 | 122250 |
| OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2020-08-14 | 2020-09-15 | 122257 |
| OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2021-03-05 | 2021-03-09 | 135159 |
| OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2021-03-11 | 2021-03-13 | 135546 |
| OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2021-09-23 | 2021-10-27 | 146048 |
| OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2021-12-14 | 2021-12-17 | 151115 |
| OMNIPAQUE 240 | 518MG | SOLUTION | Avoided shortage | 2022-05-13 | 2022-05-20 | 160522 |
| OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2022-05-13 | 2023-03-01 | 160525 |
| OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2022-05-13 | 2023-03-24 | 160528 |
| OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2022-05-13 | 2023-01-11 | 160531 |
| OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2022-06-03 | 2022-09-09 | 161863 |
| OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2022-10-03 | 2022-11-01 | 170954 |
| OMNIPAQUE 240 | 518MG | SOLUTION | Avoided shortage | 2022-11-30 | 2023-01-25 | 176387 |
| OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2023-04-04 | 2023-04-14 | 188698 |
| OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2024-01-26 | 2024-02-13 | 217288 |
| OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2024-03-11 | 2024-04-02 | 221863 |
| OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2024-04-23 | 2024-05-04 | 225946 |
| OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2024-05-28 | 2024-06-12 | 229037 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| Metastron | 37 MBq/mL | Solution | Discontinued | 2018-10-12 | 2019-02-01 | 63929 |
| OMNIPAQUE 180 | 388MG | SOLUTION | Discontinued | 2023-01-31 | 2023-02-22 | 182757 |
| OMNIPAQUE 240 | 518MG | SOLUTION | Discontinued | 2023-01-31 | 2023-03-18 | 182760 |
| OMNISCAN | 287MG | SOLUTION | Discontinued | 2023-01-31 | 2023-03-25 | 182742 |
| THALLOUS CHLORIDE TI 201 INJECTION | 37MBq | SOLUTION | Discontinued | 2020-12-04 | 2021-06-05 | 129592 |
Showing 1 to 5 of 5